Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
3.180
-0.060 (-1.85%)
Jan 29, 2026, 2:21 PM EST - Market open
Aquestive Therapeutics Market Cap
Aquestive Therapeutics has a market cap or net worth of $387.97 million as of January 29, 2026. Its market cap has increased by 36.82% in one year.
Market Cap
387.97M
Enterprise Value
301.50M
1-Year Change
36.82%
Ranking
Category
Stock Price
$3.18
Market Cap Chart
Since July 25, 2018, Aquestive Therapeutics's market cap has decreased from $393.23M to $387.97M, a decrease of -1.34%. That is a compound annual growth rate of -0.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 395.29M | -49.85% |
| Dec 31, 2025 | 788.14M | 142.81% |
| Dec 31, 2024 | 324.59M | 140.67% |
| Dec 29, 2023 | 134.87M | 176.07% |
| Dec 30, 2022 | 48.85M | -68.73% |
| Dec 31, 2021 | 156.24M | -13.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emergent BioSolutions | 641.79M |
| BGM Group | 632.82M |
| Organogenesis Holdings | 506.38M |
| Kamada | 503.43M |
| SIGA Technologies | 488.39M |
| Canopy Growth | 444.54M |
| Eton Pharmaceuticals | 403.87M |
| Akebia Therapeutics | 400.70M |